What Is a ‘Tolerable’ Dose? AACR-Industry Roundtable 2025 Examines Dose Optimization
Experts discussed challenges and opportunities for dose optimization of cancer treatments at the 2025 AACR-Industry Roundtable.
Experts discussed challenges and opportunities for dose optimization of cancer treatments at the 2025 AACR-Industry Roundtable.
Former Philadelphia Mayor Michael Nutter received a humanitarian award for his work as a prostate cancer advocate and dedication...
Researchers examined how the molecular features of Hodgkin lymphomas differ between young and older patients.
Bianca Islam, MD, PhD, examines how social determinants of health impact cancer patients and what is being done to...
August’s edition of Editors’ Picks includes biomarkers of immunotherapy response, individualized colorectal screening guidelines, and other exciting research.
The Global Scholar Alumni Committee reflects on their progress after the first year in helping the careers of young...
New research improves physicians' “molecular chess” game against thyroid cancer to overcome resistance to treatments.
Researchers developed a model that uses the gut microbiome to predict if a patient's tumor would have a response...
Expanding clinical trial eligibility requirements can help increase participation and more accurately show how treatments work in a real-world...
This quarter's round-up of cutting-edge cancer research includes a way to fight chemo brain, controlling cancer cell death, and...
New cervical cancer self-screening options and a portable blood test device could lead to changes in at-home cancer screening...